Cargando…
Erythema multiforme after initiation of anti interleukin-12/23 (ustekinumab) treatment for plaque psoriasis
Autores principales: | Burlando, Martina, Molle, Mattia Fabio, Antonelli, Chiara Trambaiolo, Cozzani, Emanuele, Parodi, Aurora |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7200193/ https://www.ncbi.nlm.nih.gov/pubmed/32382624 http://dx.doi.org/10.1016/j.jdcr.2020.03.002 |
Ejemplares similares
-
Bulky Condyloma Acuminata following Ustekinumab Treatment for Plaque Psoriasis: A Case Report
por: Burlando, Martina, et al.
Publicado: (2021) -
Dimethyl fumarate as a safe and effective therapy for recalcitrant psoriasis in comorbid patients
por: Burlando, Martina, et al.
Publicado: (2022) -
Treatment of moderate-to-severe plaque psoriasis with tildrakizumab in the real-life setting
por: Burlando, Martina, et al.
Publicado: (2021) -
Reticular Erythematous Mucinosis: Exclusive Involvement of the Axillary Region
por: Burlando, Martina, et al.
Publicado: (2021) -
Review of ustekinumab, an interleukin-12 and interleukin-23 inhibitor used for the treatment of plaque psoriasis
por: Koutruba, Nora, et al.
Publicado: (2010)